Home » Swifter, Tougher Enforcement Actions Are Expected
Swifter, Tougher Enforcement Actions Are Expected
May 6, 2010
Four weeks after an inspection, KV Pharmaceuticals agreed to a consent decree with the FDA. Six weeks after an inspection, the FDA seized products from
three facilities of Caraco Pharmaceutical Laboratories. And in August, FDA Commissioner Margaret Hamburg announced that the FDA would give companies just
15 business days to respond to Form 483 observations.